About Panacea Life Sciences Holdings, (PLSH) data
Data as of August 14, 2026.
Panacea Life Sciences Holdings, (PLSH) has 6.51K shares sold short as of the latest FINRA settlement report on August 14, 2026. Short interest has increased by 100.00% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 0.83 days (days to cover).
Recent PLSH short interest history
| Settlement date | Short interest | Change | Days to cover |
|---|---|---|---|
| Aug 14, 2026 | 6,506 | 100.00% | 1.00 |
| Jul 15, 2026 | 91 | -98.39% | 1.00 |
| Jun 30, 2026 | 5,667 | 100.00% | 1.00 |
| Apr 15, 2026 | 12,131 | 100.00% | 1.00 |
| Jan 15, 2026 | 13 | 0.00% | 1.00 |
| Dec 31, 2025 | 13 | 100.00% | 1.00 |
| Oct 31, 2025 | 4,400 | -0.02% | 1.00 |
| Oct 15, 2025 | 4,401 | 100.00% | 1.00 |
| Jul 31, 2024 | 1,237 | 100.00% | 1.00 |
| Apr 15, 2024 | 1,547 | 139.47% | 1.00 |
| Mar 28, 2024 | 646 | -0.15% | 1.00 |
| Mar 15, 2024 | 647 | 0.00% | 1.00 |
Full history, charts, and borrow-fee detail are on the PLSH short interest page.
Frequently asked questions
What is the current short interest in PLSH?
As of the latest FINRA settlement dated August 14, 2026, PLSH had approximately 6,506 shares sold short. Short interest data is reported by FINRA twice per month.
How much does it cost to short PLSH?
The latest borrow fee (cost to borrow) for PLSH is 0.25% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.
What is the days to cover ratio for PLSH?
Days to cover for PLSH is approximately 0.83 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
Is PLSH a short squeeze candidate?
A squeeze needs shorts that are hard to close. PLSH trades about 7,872 shares a day and would take roughly 0.83 days to unwind current short positions, at a current borrow fee of 0.25%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.